Signaling via the large protocadherin Fat (Ft), regulated in part by its binding partner Dachsous (Ds) and the Golgi-resident kinase Four-jointed (Fj), is required for a variety of developmental functions in Drosophila. Ft and, to a lesser extent, Ds suppress overgrowth of the imaginal discs from which appendages develop and regulate the Hippo pathway [1-5] (reviewed in [6] ). Ft, Ds, and Fj are also required for normal planar cell polarity (PCP) in the wing, abdomen, and eye and for the normal patterning of appendages, including the spacing of crossveins in the wing and the segmentation of the leg tarsus (reviewed in [7] [8] [9] ). Ft signaling was recently shown to be negatively regulated by the atypical myosin Dachs [10, 11] . We identify here an additional negative regulator of Ft signaling in growth control, PCP, and appendage patterning, the Approximated (App) protein. We show that App encodes a member of the DHHC family, responsible for the palmitoylation of selected cytoplasmic proteins, and provide evidence that App acts by controlling the normal subcellular localization and activity of Dachs.
approximated Is Required for Patterning and Normal PCP Crossvein spacing and tarsal leg segmentation are extremely sensitive to changes in Fat (Ft) activity; they are disrupted in weak Ft-pathway mutants that have no obvious growth or planar cell polarity (PCP) defects. Similar disruption occurs in app 1 homozygotes: The distance between the anterior crossvein (ACV) and posterior crossvein (PCV) is reduced ( Figure 1B) , and one or more tarsal leg joints are lost or reduced (Figure S1B available online) [12] . app 1 hemizygote wings also have weak PCP defects ( Figure 1H ). We used ethyl methanesulfonate to generate additional mutations that failed to complement app 1 . Of these, app e6 was semilethal in homozygotes and hemizygotes, and escaper adults had more extensive wing PCP defects, both proximally and in a distal region between the third and fourth longitudinal veins ( Figures  1C, 1D , and 1J). They also had abdominal PCP defects ( Figure 1L ): In the anterior compartment, most hairs point in the normal posterior direction, but polarity was disturbed around the anterior-posterior (A/P) boundary (a6 and p3 in the nomenclature of [13] ) and extensively reversed in the posterior compartment (p3). app e6 appears amorphic, given that the defects were not noticeably stronger in hemizygotes.
The development of PCP in the pupal wing is accompanied by the polarized redistribution of the ''core'' planar-polarity proteins to the proximal, distal, or proximal and distal faces of single wing cells [8] . PCP mutants can be separated according to their effects on this polarization. Mutations in the core PCP proteins reduce the levels and block the polarization of the other core PCP proteins, whereas changes in ft, ds, or fj expression can reorient core PCP protein polarization along inappropriate axes [14] [15] [16] . We found that the levels of the core PCP protein Flamingo (Fmi, also known as Starry night) [17, 18] were not reduced in app e6 mutant clones (more than 30 examined) and that Fmi polarization was in some cases reoriented ( Figure 1M ). This further supports App's involvement in Ft signaling.
Identifying app
We mapped app to a portion of 69A2-A4 containing seven known or predicted genes ( Figure S2A ). app 1 , app e1 , app e3 , and app e6 all contained mutations in the 5 0 coding exons of one of these, the CG5620 Flybase gene prediction ( Figure 2B ). We constructed a UAS-driven RNAi transgene corresponding to the 5 0 end of CG5620 and expressed it in developing dorsal wings by using ap-gal4; this produced app-like wing and PCP defects on the dorsal surface ( Figures 1E and 1I) .
However, the 3 0 end of the CG5620 coding prediction is in error ( Figure S2B ). Products we obtained by using the 3 0 rapid amplification of cDNA ends (RACE) contained instead the 3 0 exon of the adjacent CG17144 prediction, as did a recent Berkeley Drosophila Genome Project expressed sequence tag (EST) [19] . We call this transcript app-RA and show below that the corresponding App-PA protein is produced in flies. Another EST predicts a shorter transcript we call app-RB. We did not find transcripts covering the entire final coding exon of CG5620 in embryonic or larval cDNA libraries or by RACE. However, the full CG5620 prediction is conserved in Drosophila pseudoobscura, suggesting that it might be utilized; we term this app-RC (predicted).
We rescued the wing and leg defects of app homozygotes by expressing UAS-app-RA, UAS-app-RB, or UAS-app-RC with either act-gal4 or en-gal4 (act-gal4 UAS-app-RA in Figure 1F and Figure S1F ). Overexpression of higher levels of UAS-app with strong drivers such as ap-gal4 or tub-gal4 also disrupted PCP in the proximal wing and abdomen (see Figure 4K ).
App Is a DHHC Protein app encodes a member of the DHHC protein family responsible for adding palmitates to cytoplasmic proteins [20, 21] . Eukaryotes contain multiple members of the DHHC family, with 8 predicted in yeast, 23 in mammals [22] , and 20 in Drosophila.
The region common to all predicted App isoforms contains four predicted transmembrane domains, with a DHHC cysteine-rich domain (DHHC-CRD) located between the second and third transmembrane domains (Figures 2A and 2B ). It is likely that the DHHC-CRD is located on the cytoplasmic side of the membrane, as in the yeast DHHC protein AKR1 [23] .
Alignments using the region common to the App isoforms indicate that App is in the same subfamily as the human ZDHHCs 9, 14, and 18 [22] and is the Drosophila protein most similar to yeast ERF2 [24] (Figure 2A and Figures S2C and S3) . The similarity between App and these proteins drops off at the Cterminal end of the common region ( Figure S2C ). The divergent C termini of App-PA and App-PC (predicted) have no significant similarity to each other or to other proteins in the database outside the drosophilids, except for a short region at the C terminus of App-PA that is similar to predicted App homologs from the insects Tribolium and Apis. App-PB has a much shorter C terminus. Because any of the putative app transcripts rescued the app leg and wing phenotypes (see above), the different C termini are dispensable for these phenotypes. app 1 contains a missense mutation N-terminal to the DHHC-CRD domain and an aberration that introduces a frameshift predicted to truncate the C-terminal end of App-PA ( Figure 2B ). app e3 contains a missense mutation that changes a conserved cysteine in the DHHC-CRD. Because the DHHC-CRD is required for palmitoyltransferase activity [25] , this supports a role for palmitoylation in Ft signaling. app e6 and app e1 contain nonsense mutations predicted to truncate the protein prior to or toward the end of the DHHC-CRD, respectively, and therefore app e6 is likely null for App function.
App Is Concentrated at the Apical Cell Cortex but Does Not Affect the Levels or Distribution of Ft or Ds
We generated two antisera, one specific for App-PA and one for the common region ( Figure 2B ). Both antisera uniformly stained embryos, imaginal discs, and pupal wings, and staining was lost from mitotic homozygous app e6 clones, confirming the expression of the App-PA isoform (anti-App-PA in Figures 2C-2F and Figure S4 ; similar results with anti-Appcommon). There is no obvious asymmetric distribution of the App protein along the proximodistal or anterior-posterior axes of imaginal discs or pupal wings. However, staining was especially strong in the apical cell cortex ( Figure 2D and Figure S4 ), and this concentration did not extend more basally to the adherens junction marker DE-cadherin ( Figure 2E ) or the septate junction marker Discs large 1 (data not shown). This is similar to the distribution of Ft and Ds [15] , and there is overlap between the regions where App, Ds, and Ft are concentrated ( Figure 2F ). This result is surprising because human ZDHHC9, 14, and 18 and yeast ERF2 are concentrated in the Golgi or ER; only a few, less similar ZDHHCs have been detected at the plasma membrane [24, [26] [27] [28] . We did not observe any significant overlap between App and Golgi or ER markers in wing discs (data not shown). Although App must traffic through the ER and Golgi, these results suggest that App is active in the plasma membrane, in or near the apical region where Ft and Ds are concentrated.
However, App does not detectably regulate Ft and Ds levels or their binding. The binding between Ft and Ds stabilizes both proteins at the cell surface in wing discs [14] [15] [16] , but app e6 clones did not affect Ft or Ds levels or distribution ( Figures 2G-2H ). Creating artificial boundaries of ft or ds expression also strongly polarizes wing PCP [14] [15] [16] clones did not affect PCP, whereas large clones only affected PCP in the regions of the wing where defects were observed in app e6 homozygotes ( Figure S5 ). There was no tendency to reorient hairs at clone boundaries ( Figure 2I and Figure S5 ), and only rarely did regions with altered PCP affect PCP in adjacent wild-type cells; these findings may be due to altered cell interactions mediated by the core polarity proteins. Sharp boundaries of UAS-app-RA misexpression (e.g., driven with the posterior driver en-gal4) also had no effect on PCP ( Figure 2J ). Anti-App staining was not altered in wing discs by ft or ds clones (data not shown). Thus, despite their colocalization, there is no evidence that App physically interacts for Ft or Ds. Figures 3B and 3F ) and disc-derived tissues; late pupal abdomens are not overgrown but have strong PCP defects ( Figure 3L ). These phenotypes were partially rescued in ft fd ; app e6 and ft fd /ft G-rv ; app e6 flies: Overgrowth and extra folding of imaginal discs were suppressed ( Figures 3D and  3H ) and lethality and abdominal PCP defects were reduced ( Figure 3M ). PCP was still defective in proximal portions of the wing but was normal in the distal wing ( Figures 3I-3K) , in contrast to the distal defects in viable ft 18 wings [33] . Thus, App acts genetically downstream of and in opposition to Ft in both growth control and PCP.
App Affects the Levels and Distribution of Dachs
The effects of app mutations on Ft signaling are strikingly similar to those caused by reducing the function of the atypical myosin Dachs [11] . Like app mutations, dachs homozygotes reduce tarsal leg segmentation (Figures S1H and S1I) and the distance between the ACV and PCV and cause mild wing PCP defects that are quite similar to those observed in null app mutants (compare Figures 4A and 4B to Figures 1B-1D ; details in Figures S6 and S7) . Like app e6 clones, d
GC13 clones had PCP defects when in regions of the wing where defects occur in d homozygotes, and Fmi polarization was reoriented in d 1 pupal wings ( Figure S5E ). d mutants also had abdominal PCP defects similar to those in app mutants: Polarity was almost normal in the anterior compartment, but abnormal near the A/P compartment boundary and reversed in the posterior compartment ( Figure 4D) .
We therefore examined the effects of App on the levels and distribution of a V5-tagged Dachs protein. Dachs:V5 normally accumulates at higher levels in the apical cell cortex in wing imaginal discs [11] , overlapping the region of high anti-App staining ( Figures S4A, S10A , and S10B). Apical Dachs accumulation was greatly reduced, although not completely eliminated, in app e6 clones ( Figures  4F-4G 00 ). We did not detect changes in the levels of basolateral or cytoplasmic Dachs:V5. Although App affects Dachs accumulation at the apical cell cortex, anti-App staining was normal in d mutant clones (data not shown).
Co-overexpression of App and Dachs:V5 greatly increased the accumulation of Dachs at the cell cortex compared with the expression of Dachs:V5 alone (compare Figure 4H to Figure 4I ). Coexpression of App also increased the efficacy of Dachs in growth and PCP. Even though overexpression of App-RA did not obviously increase growth, coexpression of App-RA and Dachs caused greater overgrowth than did the expression of Dachs alone ( Figure S8 ). Cooverexpression of Dachs and App caused more extreme PCP defects in the wing and abdomen than did the overexpression of App alone, whereas overexpression of Dachs:V5 alone did not affect PCP (compare Figures 4J-4L ; more examples in Figure S9 ).
It is likely that much or all of the app mutant phenotype is mediated by the reduction of effective Dachs at the apical cell cortex. The effects of app and d mutants are not additive: Double mutants for null app and d alleles resembled the stronger d null phenotype, as expected if App works by controlling Dachs activity (Figures 4B-4E ). Because App affects Dachs post-transcriptionally, it is unlikely that overexpressed Dachs would fully rescue the app null. Nonetheless, overexpression of UAS-d with ap-gal4 or en-gal4 rescued the wing PCP defects normally found in the distal wing of app e6 mutants (Figures 4M and 4M 0 ) and partly rescued the crossvein spacing and leg-joint defects of app e6 ( Figures  S1G and S6) . That Dachs retains some activity in the absence of App is consistent with the low but significant levels of Dachs that remain at the apical cell cortex in app e6 clones (Figures 4F-4G ). Different DHHC proteins can palmitoylate the same target (e.g., see [34] ), so other Drosophila DHHC proteins may be supplying residual activity in the absence of App.
Conclusions
The App palmitoyltransferase acts in opposition to the Ft pathway, largely or wholly by controlling the apical-cell-cortex localization and the activity of the atypical myosin Dachs. This localization is probably required for full Dachs activity. For growth control, this localization would place Dachs near not only Ft, but also the Hippo pathway member Warts. Warts is concentrated near the cell cortex, with an apical bias that overlaps the region of strong App and Dachs accumulation ( Figures S10C and S10D) . Dachs binds Warts and may thereby regulate the Hippo pathway, accounting for its effects on Ftdependent growth control [4] .
As shown here and elsewhere [11] , Dachs also modulates the effects of Ft signaling on PCP. It is not clear whether this modulation is also mediated through changes in Warts activity. Warts is thought to act by changing the activity of the transcription factor Yorkie [6] , an effect that would not directly confer polarity. Moreover, Dachs was reported to accumulate preferentially on the distal faces of some wing-disc cells [11] , suggesting that Dachs is involved in cell polarization independent on any effect on transcription, probably via as-yet-unknown binding partners.
It remains possible that Dachs is palmitoylated by App. However, there is no precedent for palmitoylation of a myosin, nor does Dachs score highly when we use an algorithm that detects palmitoylation sites [35] . Nor have we detected Dachs palmitoylation by using the acylbiotin-exchange technique [36] . The effect of App may thus be less direct, palmitoylating a binding partner or regulator of Dachs. Although Dachs is a myosin, portions of Dachs are unique and lack known protein-interaction motifs [11, 37] . Warts is the only proven binding partner for Dachs, but app e6 clones did not affect the levels or cell-cortex localization of Myc-tagged Warts in wing discs ( Figure S10E) .
Given that the human and yeast DHHC proteins that App most resembles palmitoylate many targets [24, 25, 34] , the adult phenotypes of app mutants are surprisingly specific to the Ft pathway. One known target of ERF2 and ZDHHC9 is Ras, whose activity relies on membrane localization through both farnesylation and palmitoylation. Intriguingly, the Ras and MAPK pathways interact with the Ft pathway in growth control [38] . However, reducing Ras activity causes loss of wing veins, a phenotype not observed in app mutations, and does not cause the PCP and appendage-patterning defects of app and d mutants (e.g., [38] [39] [40] ). Moreover, reducing Ras activity via expression of a dominant negative EGF receptor did not affect the levels of Dachs:V5 in wing discs ( Figure S11 ). The different subcellular distributions of App, to the cell cortex, and ZDHHC9 and ERF2, to endomembranes, suggests they have different roles and targets, despite their strong similarity at the amino acid level. 
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